About this trial
This is performed under Vocorder project that is Co-Funded by the European Union. (Grant Agreement 101115442 VOCORDER HORIZON EIC-2022-PATHFINDERCHALLENGE-01). The projects has 9 work packages (one dedicated to the clinical study) and 12 partners (collaborators). MITERA Hospital serves as the project Coordinator as well as the leader of the clinical study.
VOCORDER aims to create a paradigm shift in healthcare monitoring by developing a portable device for continuous assessment of health through breath analysis.
Our mission is to make health monitoring seamless and non-intrusive, empowering individuals and healthcare professionals with real-time data and proactive health management.
Our vision is to make continuous health monitoring a part of everyday life, helping in early disease detection and management. We are on a mission to create accessible, easy-to-use technology that integrates seamlessly into daily routines.
Our objective is to create a tool designed for the discreet and continuous monitoring of human health. This involves the development and implementation of a system that can consistently assess, process, and analyze human breath. The key aim is to detect early indicators of diseases, thereby facilitating timely and proactive healthcare interventions.
Strategic objectives
1. Provide a solution for easy-to-use breath analysis able to monitor the health of any individual at any setting. 2. Develop and demonstrate the beyond state-of-the-art technologies needed to implement the VOCORDER breath analysis apparatus. 3. Develop a health monitoring apparatus people can easily integrate into their everyday life.
Scientific and technological Objectives
1. Demonstration of QCLs and ICLs monolithically integrated arrays. 2. Integrate QCLs/ICLs arrays with MPLC components for beam combing and providing high quality beam profile. 3. Implement a detector-less sensing scheme. 4. Enable AI-based breath analysis for the identification of health conditions. 5. Implement clinical studies of VOCORDER.
Eligibility criteria
Qualifiers
Patients>18 years of age of both genders
They must be able to communicate and understand the information given to them by the MITERA staff.
Suffer from the disease under investigation.
The disease must be at the earliest possible stage, i.e., the patients must not yet have started treatment.
Disqualifiers
Lack of signed consent
Lack of co-operation due to any reason
Failure to follow the recommendations on the requirements prior to the breath sampling procedure
Inability to provide a reliable breath sample
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
1Sponsors and collaborators
Mitera Hospital
Lead sponsor
ETH Zurich (Switzerland)
Collaborator
Institute of Communications and Computer Systems, Athens, Greece
Collaborator
AIDEAS OU
Collaborator
ARGOS MESSTECHNIK GMBH
Collaborator
CAILABS
Collaborator
EULAMBIA ADVANCED TECHNOLOGIES ETAIRIA PERIORISMENIS EFTHINIS
Collaborator
Vrije Universiteit Brussel
Collaborator
NEURALTECH IKE
Collaborator
UAB METIS BALTIC
Collaborator
EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT
Collaborator
ALPES LASERS SA
Collaborator